About BOLD
BOLD is a venture capital firm located in Clichy, France. As of Jun 2026, BOLD is an active investor, having invested in 24 companies, with 3 new investments in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Retail to Consumer and Enterprise Applications. Most recently it participated in the $***** Post IPO round of OliX Pharmaceuticals Overall, BOLD portfolio has seen 3 IPOs and 2 acquisitions including key companies like OliX Pharmaceuticals, Global Bioenergies and Slick. A lot of funds co-invest with BOLD, with names like Touch Capital sharing a substantial percentage of its portfolio. BOLD has team of 6 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Locations
Rounds of Entry
Series A, Seed & 2 more
Portfolio IPOs
Portfolio Soonicorns
Deals in last 12 months
BOLD's List of Top Investments
BOLD has a portfolio of 24 companies. Their most notable investments are in BORNTOSTANDOUT and Replika.Their portfolio spans across France, United States, South Korea and 5 more locations. They have invested in Retail, Consumer, Enterprise Applications and 13 other sectors, across stages such as Series A, Seed and 2 more. Here is the list of top investments by BOLD:
1. Deconstruct
Platform offering multi-category skincare products. It offers a wide range of science-backed solutions, including face and body care products, lip balms, cleansers, serums, and sunscreens. The brand also provides specialized kits such as an oily skin kit and a skin radiance routine kit. Its products cater to various skin types and concerns, including hydration, brightening, and anti-aging.
Key facts about Deconstruct
- Founded Year: 2020
- Location: Bengaluru (India)
- Annual Revenue: ₹100 - ₹500 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $10.4M
- Employee Count: 74 as on Aug 31, 2025
- Investors: Verlinvest, Kalaari Capital and 16 Others
- Latest Funding Round: Series A, Dec 24, 2024, $*****
- Highlight: Editors' Pick
2. Rembrand
Provider of AI-powered advertising solutions for in-content and social media. The company offers tools for advertisers and publishers to integrate brand messaging within digital content. It transforms social media content into advertisements and places virtual product placements within relevant scenes. The company aims to deliver advertising experiences that are more natural for viewers.
Key facts about Rembrand
- Founded Year: 2022
- Location: Palo Alto (United States)
- Stage: Series B
- Total Funding till date: $68.5M
- Employee Count: 82 as on May 31, 2026
- Investors: Greycroft, Bold Capital Partners and 8 Others
- Latest Funding Round: Series B, Nov 21, 2025, $*****
- Highlight: Editors' Pick
3. Arata
Internet-first brand of multi category beauty care products. Its catalog includes body wash, hair creams, shampoo, hair gel, lip balms, skincare products, and more. The company claims to offer natural, vegan, and cruelty-free beauty products.
Key facts about Arata
- Founded Year: 2017
- Location: Delhi (India)
- Annual Revenue: ₹50 - ₹100 Cr as on Mar 31, 2025
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $8.91M
- Employee Count: 89 as on Jul 31, 2025
- Investors: Angel List, Unilever Ventures and 41 Others
- Latest Funding Round: Series A, Sep 03, 2024, $*****
- Highlight: Editors' Pick
4. Debut
Provider and manufacturer of enzymes for biotherapeutic creation and modification. The company offers a range of enzymes that are used in the biotech industry for immobilization and other therapeutic applications. The company also provides continuous biomanufacturing cartridges, immobilized cells, immobilized enzymes for continuous biomanufacturing.
Key facts about Debut
- Founded Year: 2019
- Location: San Diego (United States)
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $126M
- Employee Count: 99 as on May 31, 2026
- Investors: EDBI, Cultivian Sandbox and 16 Others
- Latest Funding Round: Series B, Aug 26, 2025, $*****
- Highlight: Editors' Pick
Developer of RNAi therapeutics for dermal, ophthalmic, and pulmonary diseases. Its drug pipeline includes OLX101 for the treatment of Skin Scar (licensed out to Huge Inc.), OLX201 for the treatment of Lung fibrosis, OLX301 for the treatment of Wet AMD/Retinal Fibrosis, OLX701 for liver fibrosis. Other products include OLX102 for skin whitening and OLX105 to get rid of wrinkles. The company's technology is based on three types of RNA: Small interfering RNA (siRNA), Asymmetric siRNA (siRNA), and Cell-penetrating asymmetric siRNA (cp-siRNA).
Key facts about OliX Pharmaceuticals
- Founded Year: 2010
- Location: Suwon-si (South Korea)
- Stage: Public
- Employee Count: 58 as on May 31, 2026
- Investors: Kolon Investments, Smile Gate Investment and 16 Others
- Latest Funding Round: Post IPO, Jun 02, 2026, $*****
- Highlight: Public
BOLD's Year-on-Year Investment Trends
BOLD has invested in 24 companies over the last 8 years, with an average of 3 new investments annually in the last 5 years. In 2025, it made 4 investments, while as of Jun 2026, it has made 3 investments in this year. Its most recent first time investment was in OliX Pharmaceuticals and most recent follow-on round was in Debut.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 3 | 0 | 3 |
2025 | 3 | 1 | 4 |
2024 | 5 | 0 | 5 |
2023 | 4 | 1 | 5 |
2022 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
2020 | 1 | 0 | 1 |
2019 | 2 | 0 | 2 |
2018 | 1 | 0 | 1 |
BOLD's Investments by Stage
BOLD has made 10 investments in Series A stage with an average round size of $12.2M, 8 investments in Seed stage with an average round size of $5M, 2 investments in Post IPO stage with an average round size of $44.6M and 2 investments in Series B stage with an average round size of $24.8M.Stage of entry | No. of Investments |
|---|---|
Series A | 10 |
Seed | 8 |
Post IPO | 2 |
Series B | 2 |
Note: We have considered here, only first round of investments
BOLD's Investments by Sector
BOLD has a diverse portfolio, with companies operating in the Consumer, Consumer Goods, Retail, High Tech and Life Sciences. Notably, it has invested in 18 Tech companies, 11 Consumer (B2C) companies, 8 Enterprise (B2B) companies and at least 3 companies focusing on Software.Sector | No. of Investments |
|---|---|
Consumer | 10 |
Consumer Goods | 9 |
Retail | 9 |
High Tech | 5 |
Life Sciences | 4 |
Others | 22 |
Note: We have considered here, only first round of investments
BOLD's Investments by Geography
BOLD has made most investments in United States (6), followed by France where it has made 5 investments.Country | No. of Investments |
|---|---|
United States | 6 |
France | 5 |
South Korea | 4 |
India | 3 |
Switzerland | 2 |
Others | 2 |
Note: We have considered here, only first round of investments
BOLD's recent investments
BOLD has made 3 investments in 2026 so far. OliX Pharmaceuticals and hanni are the latest among them.Here are the most recent investments by BOLD:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 02, 2026 | South Korea | Post IPO | 7075 | ||
Apr 17, 2026 | United States | Series A | 2275 | - | |
Mar 24, 2026 | India | Series A | 5373 | [+7] | |
Aug 26, 2025 | United States | Series B | 8222 | ||
Feb 18, 2025 | South Korea | Series A | 6717 |
IPOs and Publicly Listed companies in BOLD's Portfolio
3 of BOLD's portfolio companies have become public. OliX Pharmaceuticals got listed on the Korea Exchange (KRX), in Jul 2018 at marketcap of $210M and Carbios got listed on the Euronext Exchange (Euronext).Here are BOLD's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 20, 2018 | Jun 02, 2026 | Post IPO | 9530 | |
Dec 19, 2013 | Jun 25, 2019 | Post IPO | 5366 | |
Jun 09, 2011 | - | - | 4139 |
Acquired companies in BOLD's Portfolio
2 companies from BOLD's portfolio have been acquired. The most recent acquisition was Slick in Mar 2026 by DaySmart for $*****.Here are BOLD's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 31, 2026 | - | - | 8435 | |
Jan 10, 2024 | Mar 24, 2021 | Seed | 5429 |
_1581509048701.png?devicePixelRatio=2&height=20&width=20){kind=logo}
_1575377389381.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Team profile of BOLD
BOLD has a team of 6 members including 1 Partner and 3 Principals located in France and Netherlands. BOLD's team does not sit on the board of any company as of now.Here is a list of all team members in BOLD:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | France | - | - | |
Principal | Amsterdam | - | ||
Principal | Paris | - | - | |
Principal | France | - | - |
Co-investors of BOLD
Over the past 8 years, 127 investors have co-invested in BOLD's portfolio companies. This includes funds and angels.
- Invested before BOLD: Europa, Kalaari Capital and 76 others have invested in rounds before BOLD. There are 2 companies where Europa has invested before BOLD and 1 company where Kalaari Capital has invested before BOLD.
- Top Co-investors of BOLD: 43 investors entered a company along with BOLD. These include investors like Touch Capital (2 companies).
- Invested after BOLD: A total of 6 investors have invested in BOLD's portfolio after their investments. Top Investors include INX International Ink (1 company), EDBI (1 company) and Wealthberry (1 company).
Recent News related to BOLD
•
•
CHOSEN Secures $5 Million Series A Funding Led by Fireside Ventures to Enhance R&D and Expand.Viestories•May 04, 2026•CHOSEN, , Fireside Ventures, L'Oreal and 7 others
•
L’Oréal’s BOLD venture fund invests in premium body care brand HanniCosmetics Business•Apr 20, 2026•BOLD, hanni
•
•
L'Oréal invests in the Korean luxury perfumery BorntostandoutFortuneo•Feb 18, 2025•L'Oreal, BORNTOSTANDOUT, BOLD, Touch Capital and 2 others
•
Deconstruct Skincare grows 1000% to ₹200 Cr, raises ₹65 Cr from L’Oréal’s VC fund BOLD, V3 ventures and DSG Consumer PartnersIndiaeducationdiary.in•Jan 22, 2025•Deconstruct, V3 Ventures, DSG Consumer Partners, L'Oreal and 3 others
•
Rembrandt secures $23M Series A funding led by super{set}, with The Trade Desk & Naver also investing.TMC•Jan 02, 2025•Rembrand, The Trade Desk, Superset, Naver and 5 others
•
Mobiltech Attracts Additional Series B Investment of 3 Billion Won “Spurring Global Business and IPO”Wowtale•Jan 02, 2025•MobilTech, CJ Investment, NAVER D2 Startup Factory, Naver and 6 others
•
Indian hair care startup raises $4m series ABEAMSTART•Dec 21, 2024•Arata, Unilever Ventures, BOLD, Skywalker Investment Advisors and 2 others
•
L'Oreal, Evonik join $38.6 million funding round for biotech start-up AbolisFashion Network•Sep 13, 2024•L'Oreal, Evonik, Abolis, Evonik Venture Capital and 5 others
